1,2-dipalmitoylphosphatidylcholine has been researched along with Metastase in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ando, H; Asai, T; Dewa, T; Kato, H; Koide, H; Maeda, N; Nango, M; Oku, N; Yokota, M; Yonenaga, N | 1 |
Cossu, F; Melis, G; Rombi, G | 1 |
2 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and Metastase
Article | Year |
---|---|
Susceptibility of PTEN-positive metastatic tumors to small interfering RNA targeting the mammalian target of rapamycin.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Cell Proliferation; Ethylenediamines; Liposomes; Male; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neovascularization, Pathologic; Phosphatidylethanolamines; Phosphorylation; Polyethylene Glycols; PTEN Phosphohydrolase; RNA, Small Interfering; TOR Serine-Threonine Kinases | 2015 |
mAb-labeled liposomes in breast cancer cell targeting. Therapeutics and diagnostic use of polyspecific artificial carriers.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antibodies, Monoclonal; Brain Neoplasms; Breast Neoplasms; Drug Carriers; Female; Humans; Iodine Radioisotopes; Liposomes; Liver Neoplasms; Neoplasm Metastasis; Phosphatidylethanolamines; Radioimmunodetection; Technetium | 1993 |